
Lionco Pharmaceutical Group Co.,Ltd.
SSE:603669.SS
5.23 (CNY) • At close June 6, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Lionco Pharmaceutical Group Co.,Ltd. |
Symbool | 603669.SS |
Munteenheid | CNY |
Prijs | 5.23 |
Beurswaarde | 3,679,530,973 |
Dividendpercentage | 0% |
52-weken bereik | 3.45 - 9.54 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Ling Ping Tao |
Website | https://www.lingkang.com.cn |
An error occurred while fetching data.
Over Lionco Pharmaceutical Group Co.,Ltd.
Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in China. The company offers nutrition, antimicrobial, antiviral, digestion, cardiovascular, detoxification, anti-tumor, and other products. It also operates research institutes that specialize in the research of chemical drugs, natural medicines, and biological drugs. Lionco Pharmaceutical
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)